COVID-19 Dominates Clinical Trials in Recent Years!

Published on May 14, 2022

In the fast-paced world of clinical research, COVID-19 has stolen the show! Like a superstar athlete outperforming other contenders three to one, this novel virus has been the center of attention in clinical trials during 2020-21. Just picture a packed stadium where COVID-19 is the star player, effortlessly scoring goals while other conditions struggle to keep up. These findings from the patient empowerment organization With Power reveal the unprecedented focus on studying and understanding this global health crisis. It’s no surprise that COVID-19 took the spotlight; its impact has been felt worldwide, disrupting lives and economies. However, it’s important not to overlook other pressing medical conditions that still demand attention and research. COVID-19 may be the reigning champion, but there are countless underdogs waiting for their turn to be studied and understood. Let’s continue exploring the latest research to empower ourselves with knowledge and make informed choices for our health.

COVID-19 was the most studied condition in clinical trials during 2020-21, a new analysis from the patient empowerment organization With Power found.

Read Full Article (External Site)

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes:

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>